Granules India Ltd — Q4 FY26
Granules India delivered a strong Q4 FY26 with revenue of ₹1,476 crore (+23% YoY), EBITDA of ₹352 crore (+40% YoY), and PAT of ₹202 crore (+33% YoY).
bullish
medium
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q3 FY26
Peptide CDMO to turn EBITDA positive in Q4 FY26
Management expects meaningful improvement in Q4 performance, with the business reaching EBITDA breakeven in the current quarter.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q3 FY26
Product launches from GLS facility in next 1-2 quarters
At least one or two existing products will be launched from GLS to cater to additional demand, with incremental revenue expected.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1